U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07136025) titled 'The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System' on Aug. 18.
Brief Summary: Severe asthma is a complex and heterogeneous disease. Patients with severe asthma can present with different types of airway inflammation, and are often accompanied by a variety of comorbidities and risk factors. Identification of potentially modifiable factors affecting prognosis, that is, "treatable characteristics", and individualized bundle management based on these characteristics may help to improve the quality of life of patients with asthma and improve the level of asthma c...